News

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.34 crore in the quarter ended March 2026 as against net loss of Rs 8.27 crore during the previous quarter ended March 2025. Sales rose 11.64% to Rs 6.81 crore in the quarter ended March 2026 as against Rs 6.10 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 16.93 crore in the year ended March 2026 as against net loss of Rs 26.94 crore during the previous year ended March 2025. Sales declined 45.21% to Rs 23.73 crore in the year ended March 2026 as against Rs 43.31 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.816.10 12 23.7343.31 -45 OPM %-12.63-88.69 --22.97-34.70 - PBDT-0.77-6.68 88 -10.51-20.23 48 PBT-2.34-8.25 72 -16.93-26.92 37 NP-2.34-8.27 72 -16.93-26.94 37 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net Loss of Krebs Biochemicals & Industries reported to Rs 3.13 crore in the quarter ended December 2025 as against net loss of Rs 7.74 crore during the previous quarter ended December 2024. Sales declined 36.62% to Rs 7.27 crore in the quarter ended December 2025 as against Rs 11.47 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales7.2711.47 -37 OPM %3.99-41.06 - PBDT-1.50-6.02 75 PBT-3.13-7.74 60 NP-3.13-7.74 60 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News